Cover -- Contents -- List of Figures and Tables -- List of Abbreviations -- List of Contributors -- Preface -- Part 1 What is Compliance? -- 1 Patient Compliance: Setting the Scene -- 2 View from the Real World -- 3 Health Economic Aspects of Patient Non-compliance -- Part 2 The Challenge of Compliance -- 4 Patient Compliance in the Prevention and Treatment of Cardiovascular Disease -- 5 Patient Compliance: A French Perspective -- Part 3 Building For Success -- 6 Building in Compliance from the Start -- 7 Formulating for Compliance Success -- 8 Sweetening the Pill: Compliance and Clinical Trials -- 9 The Role of Pharma's Field-Based Professionals in Patient Compliance -- 10 The Use of Interactive Communications Technology in Disease Management and Compliance / Persistence Programmes -- 11 Patient Compliance: Putting Interventions Into Practice -- Part 4 Achieving Compliance: Looking to the Future -- 12 No Quick Fix: Shared Decision-making and Tailored Patient Support as the Route to More Effective Medicine-taking -- 13 The Role of the Expert Patient in Compliance and Concordance -- 14 Patient Compliance: A Complex Picture Emerges -- Index -- A -- B -- C -- D -- E -- F -- G -- H -- I -- J -- L -- M -- N -- O -- P -- Q -- R -- S -- T -- U -- W.

Vast global resources are ploughed into the delivery of treatment interventions ranging from diet and lifestyle advice to complex surgery. In all cases, whatever the intervention, unless the recipient is engaged with the process and understands why the intervention has been offered and the part they play in its success, compliance is an issue. Even where the individual does engage and understand, he or she may choose not to comply. Non-compliance is estimated to cost the pharma industry US70 billion per year. No figures exist for the cost to healthcare insurers and public health but non-compliance is undoubtedly one of the top five issues facing both drug developers and healthcare providers. During clinical trials, non-compliance undermines the accuracy of the data generated from the whole trial as well as particular aspects such as the efficacy of different dosages. This book explores the key factors which drive compliance and the part that healthcare professionals can play in improving this, with the key underlying goal of improving public health in its broadest sense.

Description based on publisher supplied metadata and other sources.

Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2018. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries.